from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0103c/ctpB

LFCtreatmentdescriptionclass of inhibitor

-0.758

Amikacinug/mL Amikacintranslation

-1.668

Cap5-10ug/mL Capreomycintranslation

-1.817

Rox10-50 ug/mL Roxithromycintranslation

0.097

SM2-5 ug/mL Streptomycintranslation

0.301

Tet5-10 ug/mL Tetracyclinetranslation

1.486

Rif0.2-5ug/mL Rifampicintranscription

0.508

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.366

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.175

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.357

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.450

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.104

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.406

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.380

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.325

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.232

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.835

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.590

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.171

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.105

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.152

KCN5-20 ug/mL Potassium cyaniderespiration

0.220

NaN30.2-2 mM Sodium aziderespiration

-0.815

Nigericin50 uM Nigericinrespiration

-0.203

TRC10-150 ug/mL Triclosanrespiration

-1.152

TRZ10-25 ug/mL Thioridazinerespiration

-1.876

Valinomycin0.5-10 uM Valinomycinrespiration

-0.765

ZnSO42 mM ZnSO4respiration

-0.720

menadione6-10 ug/mL Menadionerespiration

-0.192

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.115

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.116

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.667

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.154

NRP_1Non-replicating persistence stage 1dosRassociated

0.049

Amp0.2mg/mL AmpicillincellWall

-0.089

Cephalexin20-100 ug/mL CephalexincellWall

-0.246

Cerulenin0.32-5 ug/mL CerulenincellWall

1.298

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.451

EMB10-20 ug/mL EthambutolcellWall

-0.016

Eta12-40 ug/mL EthionamidecellWall

0.210

INH0.2-0.4 ug/mL IsoniazidcellWall

0.152

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.981

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.371

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.322

BZA0.12 mg/mL BenzamidearomaticAmides

0.928

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.496

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.261

H2O24 mM hydrogen peroxideDNAdamaging

-0.048

Levo10 ug/mL LevofloxacinDNAdamaging

0.701

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.255

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.184

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.810

UVUV-irradiationDNAdamaging

-1.182

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.127

Antimycin12.5-50 ug/mL Antimycin A?

-0.877

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.034

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.065

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.265

PA8240.2-2 ug/mL PA-824?

-0.192

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.120

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.934

Verapamil50 uM Verapamil?

-0.978

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.001

methoxatin10-20 ug/mL Methoxatin?